MATTHEW DAY: Open Payments
NPI 1518413137 · LANGHORNE, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,245 in 143 payments from 18 companies in 2025. Trend: 2023 $1,839 · 2024 $3,728 · 2025 $2,245
Food & beverage: $2,245
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 30 | $397 |
| Novartis Pharmaceuticals Corporation | 11 | $281 |
| Regeneron Healthcare Solutions, Inc. | 8 | $246 |
| PFIZER INC. | 14 | $233 |
| Janssen Biotech, Inc. | 32 | $190 |
| GENZYME CORPORATION | 6 | $175 |
| Incyte Corporation | 8 | $141 |
| Ortho Dermatologics, a division of Bausch Health US, LLC | 6 | $125 |
| Galderma Laboratories, L.P. | 6 | $111 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 4 | $80 |
Products named: DUPIXENT, SKYRIZI, CIBINQO, TREMFYA, COSENTYX, OPZELURA, Cabtreo, RINVOQ.
Industry payments across PA — which companies pay providers there.
